Publications by authors named "Katsumi Urata"

Background: Transabdominal ultrasound is used to detect fecal impaction, but the rectum is difficult to visualize without bladder urine or with gastrointestinal gas.

Objective: We developed a transgluteal cleft approach that is unaffected by these factors and sought to determine if our ultrasound method could detect and classify fecal matter in the lower rectum using this approach.

Methods: We classified ultrasound images from hospitalized patients into four groups: Group 1 (bowed and rock-like echogenic areas), Group 2 (irregular and cotton candy-like hyperechoic areas), Group 3 (flat and mousse-like hyperechoic areas), and Group 4 (linear echogenic areas in the lumen).

View Article and Find Full Text PDF

Purpose: Lewy body disease (LBD) is comprised of a spectrum of diseases that includes Parkinson's disease (PD), PD dementia (PDD) and dementia with LBD (DLBD), an array of dementia, and motor symptoms. Low uptake of myocardial meta-iodobenzylguanidine (MIBG) validates diagnosis of LBD. Psychiatric symptoms sometimes precede atypical Parkinsonian syndromes in LBD.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Katsumi Urata"

  • - Katsumi Urata's recent research primarily focuses on innovative ultrasound techniques for medical diagnostics, specifically developing a transgluteal cleft approach for accurately assessing fecal matter in the lower rectum, enhancing the detection of fecal impaction in challenging conditions.
  • - The study evaluates the accuracy of this new ultrasound method by classifying images into four distinct groups based on the characteristics of the fecal matter observed, providing a systematic approach to interpretation.
  • - In addition to gastrointestinal issues, Urata's work also explores the detection of Lewy body disease (LBD) in patients exhibiting psychiatric symptoms through myocardial scintigraphy, highlighting the relationship between mental health disorders and neurodegenerative conditions.